Contact Us
Drug Search Results
More Filters [+]

Auriclosene

Alternative Names: auriclosene, nvc-422, nvc422, nvc 422, CD07223, CD-07223
Latest Update: 2015-12-02
Latest Update Note: Clinical Trial Update

Product Description

Auriclosene is a non-antibiotic, fast-acting, broad-spectrum antimicrobial, which exhibits potential for the rapid decolonization of a range of urologic pathogens, including the urease-producing Proteus mirabilis. (Sourced from: https://www.clinicaltrials.gov/ct2/show/NCT02130518)

Mechanisms of Action: Bacterial Growth Inhibitor,Viral Replication Blocker

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Topical,Ophthalmic

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: NovaBay
Company Location: EMERYVILLE CA 94608
Company CEO: Justin Hall
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Auriclosene

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Impetigo

Phase 2: Conjunctivitis, Viral|Conjunctivitis, Inclusion|Impetigo|Bacteriuria|Acne Vulgaris|Spinal Cord Injuries|Proteus Infections|Urinary Tract Infections|Urinary Bladder, Neurogenic|Conjunctivitis, Bacterial

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CL1401

P2

Unknown status

Urinary Tract Infections|Proteus Infections

2015-12-01

BACTOvation™

P2

Completed

Conjunctivitis, Bacterial

2014-12-01

BAYnovation™

P2

Completed

Conjunctivitis, Viral|Conjunctivitis, Inclusion

2014-05-01

RD.06. SPR. 18216

P3

Completed

Impetigo

2013-08-01

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions